CRL Annual Total Debt
$3.07 B
-$30.89 M-1.00%
30 December 2023
Summary:
As of January 20, 2025, CRL annual total debt is $3.07 billion, with the most recent change of -$30.89 million (-1.00%) on December 30, 2023. During the last 3 years, it has risen by +$906.33 million (+41.96%). CRL annual total debt is now -1.00% below its all-time high of $3.10 billion, reached on December 31, 2022.CRL Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL Quarterly Total Debt
$2.76 B
-$78.48 M-2.77%
28 September 2024
Summary:
As of January 20, 2025, CRL quarterly total debt is $2.76 billion, with the most recent change of -$78.48 million (-2.77%) on September 28, 2024. Over the past year, it has dropped by -$306.89 million (-10.01%). CRL quarterly total debt is now -19.18% below its all-time high of $3.41 billion, reached on June 25, 2022.CRL Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.0% | -10.0% |
| 3 y3 years | +42.0% | -10.0% |
| 5 y5 years | +83.8% | -10.0% |
CRL Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1.0% | +5.1% | -19.2% | at low |
| 5 y | 5-year | -1.0% | +51.4% | -19.2% | +36.3% |
| alltime | all time | -1.0% | >+9999.0% | -19.2% | +1659.9% |
Charles River Laboratories International Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.76 B(-2.8%) |
| June 2024 | - | $2.84 B(-7.8%) |
| Mar 2024 | - | $3.08 B(+0.4%) |
| Dec 2023 | $3.07 B(-1.0%) | $3.07 B(+5.6%) |
| Sept 2023 | - | $2.90 B(-5.7%) |
| June 2023 | - | $3.08 B(-2.6%) |
| Mar 2023 | - | $3.16 B(+2.1%) |
| Dec 2022 | $3.10 B(+6.2%) | $3.10 B(-7.6%) |
| Sept 2022 | - | $3.35 B(-1.8%) |
| June 2022 | - | $3.41 B(+14.5%) |
| Mar 2022 | - | $2.98 B(+2.2%) |
| Dec 2021 | $2.92 B(+35.0%) | $2.92 B(-8.0%) |
| Sept 2021 | - | $3.17 B(+5.6%) |
| June 2021 | - | $3.00 B(+24.8%) |
| Mar 2021 | - | $2.40 B(+11.3%) |
| Dec 2020 | $2.16 B(+6.7%) | $2.16 B(-1.3%) |
| Sept 2020 | - | $2.19 B(-10.1%) |
| June 2020 | - | $2.43 B(-3.9%) |
| Mar 2020 | - | $2.53 B(+25.0%) |
| Dec 2019 | $2.02 B(+21.4%) | $2.02 B(-1.4%) |
| Sept 2019 | - | $2.05 B(-6.8%) |
| June 2019 | - | $2.20 B(+29.6%) |
| Mar 2019 | - | $1.70 B(+1.9%) |
| Dec 2018 | $1.67 B(+45.7%) | $1.67 B(-1.0%) |
| Sept 2018 | - | $1.68 B(-7.8%) |
| June 2018 | - | $1.83 B(+61.4%) |
| Mar 2018 | - | $1.13 B(-1.1%) |
| Dec 2017 | $1.15 B(-7.3%) | $1.15 B(-3.2%) |
| Sept 2017 | - | $1.18 B(+3.5%) |
| June 2017 | - | $1.14 B(-4.5%) |
| Mar 2017 | - | $1.20 B(-3.0%) |
| Dec 2016 | $1.24 B(+43.1%) | $1.24 B(-1.9%) |
| Sept 2016 | - | $1.26 B(-7.8%) |
| June 2016 | - | $1.36 B(+58.4%) |
| Mar 2016 | - | $861.86 M(-0.1%) |
| Dec 2015 | $863.03 M(+11.7%) | $863.03 M(+1.2%) |
| Sept 2015 | - | $852.40 M(+10.3%) |
| June 2015 | - | $772.77 M(-1.7%) |
| Mar 2015 | - | $786.41 M(+1.8%) |
| Dec 2014 | $772.46 M(+16.4%) | $772.46 M(-1.8%) |
| Sept 2014 | - | $786.72 M(-3.3%) |
| June 2014 | - | $813.55 M(+27.0%) |
| Mar 2014 | - | $640.81 M(-3.5%) |
| Dec 2013 | $663.79 M(-0.4%) | $663.79 M(+3.6%) |
| Sept 2013 | - | $640.48 M(+0.7%) |
| June 2013 | - | $635.93 M(-2.0%) |
| Mar 2013 | - | $648.89 M(-2.6%) |
| Dec 2012 | $666.52 M | $666.52 M(-0.3%) |
| Sept 2012 | - | $668.75 M(-2.5%) |
| June 2012 | - | $686.23 M(-2.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $704.32 M(-1.9%) |
| Dec 2011 | $717.95 M(+2.4%) | $717.95 M(-3.0%) |
| Sept 2011 | - | $740.32 M(-6.2%) |
| June 2011 | - | $789.41 M(-7.9%) |
| Mar 2011 | - | $856.82 M(+22.3%) |
| Dec 2010 | $700.85 M(+42.2%) | $700.85 M(-2.5%) |
| Sept 2010 | - | $718.89 M(+64.8%) |
| June 2010 | - | $436.21 M(-8.0%) |
| Mar 2010 | - | $474.25 M(-3.8%) |
| Dec 2009 | $492.83 M(-14.5%) | $492.83 M(-1.1%) |
| Sept 2009 | - | $498.34 M(-4.5%) |
| June 2009 | - | $521.89 M(+2.4%) |
| Mar 2009 | - | $509.53 M(-11.6%) |
| Dec 2008 | $576.10 M(+12.9%) | $576.10 M(+6.2%) |
| Sept 2008 | - | $542.71 M(+3.9%) |
| June 2008 | - | $522.30 M(+2.4%) |
| Mar 2008 | - | $510.11 M(+0.0%) |
| Dec 2007 | $510.05 M(-10.8%) | $510.05 M(-1.5%) |
| Sept 2007 | - | $517.83 M(-3.4%) |
| June 2007 | - | $535.91 M(-3.1%) |
| Mar 2007 | - | $553.31 M(-3.3%) |
| Dec 2006 | $572.06 M(+93.2%) | $572.06 M(-4.8%) |
| Sept 2006 | - | $600.66 M(-1.3%) |
| June 2006 | - | $608.53 M(+98.2%) |
| Mar 2006 | - | $307.06 M(+3.7%) |
| Dec 2005 | $296.17 M(-56.9%) | $296.17 M(-21.7%) |
| Sept 2005 | - | $378.28 M(-7.0%) |
| June 2005 | - | $406.55 M(-39.0%) |
| Mar 2005 | - | $666.64 M(-2.9%) |
| Dec 2004 | $686.85 M(+269.9%) | $686.85 M(+269.3%) |
| Sept 2004 | - | $185.96 M(-0.4%) |
| June 2004 | - | $186.63 M(+0.2%) |
| Mar 2004 | - | $186.23 M(+0.3%) |
| Dec 2003 | $185.68 M(-3.5%) | $185.68 M(-2.1%) |
| Sept 2003 | - | $189.76 M(-0.1%) |
| June 2003 | - | $189.87 M(+0.0%) |
| Mar 2003 | - | $189.85 M(-1.4%) |
| Dec 2002 | $192.48 M(+22.8%) | $192.48 M(+2.1%) |
| Sept 2002 | - | $188.59 M(-0.2%) |
| June 2002 | - | $189.05 M(-28.0%) |
| Mar 2002 | - | $262.66 M(+67.5%) |
| Dec 2001 | $156.80 M(-22.7%) | $156.80 M(-19.4%) |
| Sept 2001 | - | $194.65 M(-3.9%) |
| June 2001 | - | $202.56 M(-18.5%) |
| Mar 2001 | - | $248.49 M(+22.5%) |
| Dec 2000 | $202.91 M(-47.4%) | $202.91 M(-0.1%) |
| Sept 2000 | - | $203.09 M(-49.2%) |
| June 2000 | - | $400.02 M(+0.5%) |
| Mar 2000 | - | $398.14 M |
| Dec 1999 | $386.04 M(>+9900.0%) | - |
| Dec 1998 | $1.58 M | - |
FAQ
- What is Charles River Laboratories International annual total debt?
- What is the all time high annual total debt for Charles River Laboratories International?
- What is Charles River Laboratories International annual total debt year-on-year change?
- What is Charles River Laboratories International quarterly total debt?
- What is the all time high quarterly total debt for Charles River Laboratories International?
- What is Charles River Laboratories International quarterly total debt year-on-year change?
What is Charles River Laboratories International annual total debt?
The current annual total debt of CRL is $3.07 B
What is the all time high annual total debt for Charles River Laboratories International?
Charles River Laboratories International all-time high annual total debt is $3.10 B
What is Charles River Laboratories International annual total debt year-on-year change?
Over the past year, CRL annual total debt has changed by -$30.89 M (-1.00%)
What is Charles River Laboratories International quarterly total debt?
The current quarterly total debt of CRL is $2.76 B
What is the all time high quarterly total debt for Charles River Laboratories International?
Charles River Laboratories International all-time high quarterly total debt is $3.41 B
What is Charles River Laboratories International quarterly total debt year-on-year change?
Over the past year, CRL quarterly total debt has changed by -$306.89 M (-10.01%)